SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?


To: JF2155 who wrote (590)3/31/1999 3:23:00 PM
From: Frederick Langford  Respond to of 2515
 
As I said before.
This company has a great deal of respect in the medical community.
and is clean as a whistle.

Fred



To: JF2155 who wrote (590)3/31/1999 3:35:00 PM
From: Sea Otter  Read Replies (1) | Respond to of 2515
 
Did you see this week's Economist? They have a great
article on large versus small biotechs. Examining the
reasons why small biotechs have not participated in
the overall market. (Sorry, no URL, they don't
have it posted electronically yet).

IMCL strikes me as a great example of a "small" firm
that could very soon join the ranks of the big players,
given the quality of the science and products. Right,
if C225 is half as good as its promise, $15 will be
very cheap.

As to buying more IMCL this morning - I broke my rules
too. Oh well. But now I'm back in and the die is cast.



To: JF2155 who wrote (590)3/31/1999 5:41:00 PM
From: Raven McCloud  Respond to of 2515
 
JF2155, you beginning to sound a little like me
when i'm on my Short podium.
How can you have a huge jump any day now, as you say,
if C225 "is half of its promise," when C225 is at least twelve
months or more away from approval.

All this discussion of IMCL prospects really is nothing
but speculation, including my own.
Any established fund will not enter the speculative nature
of IMCL until after Phase III is complete and approval
appears to be quaranteed.
Now, hedge funds will play IMCL, great volatility right now
and a lot of speculation, which hedge funds are attracted to.

No matter, whatever my position, gain or loss, may IMCL
be successful and end the suffering of millions.

Raven